Corrigendum: Monomeric C-Reactive Protein Binds and Neutralizes Receptor Activator of NF-κB Ligand-Induced Osteoclast Differentiation

A Corrigendum on
Monomeric C-Reactive Protein Binds and Neutralizes Receptor Activator of NF-κB Ligand-Induced Osteoclast Differentiation

By Jia Z-K, Li H-Y, Liang Y-L, Potempa LA, Ji S-R and Wu Y (2018). Front. Immunol. 9:234. doi: .10.3389/fimmu.2018.00234

In the original article, there was a mistake in Figure 4B as published. The lower panel of Figure 4B was erroneously assigned. The corrected Figure 4B appears below.

FIGURE 4

Figure 4 mCRP neutralizes the effects of receptor activator of NF-κB ligand (RANKL). Bone marrow-derived macrophages (BMDMs) were treated with 10 ng/mL of M-CSF and 50 ng/ml RANKL in the presence or absence of 100 μg/mL of mCRP. After treatment for 2 days, the expression of TRAP and Cathepsin K were determined by q-PCR (A). After treatment for 6 days, cells were stained for TRAP (B) and counted for the number of osteoclasts (C). Their bone resorption activities were evaluated by toluidine blue staining (D) and the quantification of eroded surface (E). The potent effects of RANKL on BMDMs were absent when treated together with mCRP. Comparable results were also obtained with Raw cells (B–E). *p < 0.05; ***p < 0.001.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.